Sal seidlitense
Sal seidlitense Brand names, Sal seidlitense Analogs
- Bitter salt
- Elliotts B Solution
- Epsom salt
- Epsom salts
- Hair salt
- Kieserite [as monohydrate]
- Magnesium Sulfate In Plastic Container
- Magnesium Sulfate, USP Grade
- Magnesium Sulphate Heptahydrate
- Magnesium Sulphate Hydrate
- Magnesium sulfate - dried
- Magnesium sulfate dried
- Magnesium sulfate heptahydrate
- Magnesium sulphate
- Magnesium sulfate anhydrous
- MgSO4
- Sal amarum
- Sal anglicum
- Sal catharticum
- Sal seidlitense
- Salts of England
- Sel d'angleterre
Sal seidlitense Brand Names Mixture
- No information avaliable
Sal seidlitense Chemical_Formula
C43H68ClNO11
Sal seidlitense RX_link
http://www.rxlist.com/cgi/generic/elidel.htm
Sal seidlitense fda sheet
Sal seidlitense msds (material safety sheet)
Sal seidlitense Synthesis Reference
No information avaliable
Sal seidlitense Molecular Weight
810.453 g/mol
Sal seidlitense Melting Point
No information avaliable
Sal seidlitense H2O Solubility
No information avaliable
Sal seidlitense State
Solid
Sal seidlitense LogP
5.099
Sal seidlitense Dosage Forms
Cream
Sal seidlitense Indication
For treatment of mild to moderate atopic dermatitis.
Sal seidlitense Pharmacology
Pimecrolimus is a chemical that is used to treat atopic dermatitis (eczema). Atopic dermatitis is a skin condition characterized by redness, itching, scaling and inflammation of the skin. The cause of atopic dermatitis is not known; however, scientists believe that it may be due to activation of the immune system by various environmental or emotional triggers. Scientists do not know exactly how pimecrolimus reduces the manifestations of atopic dermatitis, but pimecrolimus reduces the action of T-cells and mast cells which are part of the immune system and contribute to responses of the immune system. Pimecrolimus prevents the activation of T-cells by blocking the effects of chemicals (cytokines) released by the body that stimulate T-cells. Pimecrolimus also reduces the ability of mast cells to release chemicals that promote inflammation.
Sal seidlitense Absorption
Because of the low systemic absorption of pimecrolimus following topical application the calculation of standard pharmacokinetic measures such as AUC, Cmax, half-life, etc. cannot be reliably done.
Sal seidlitense side effects and Toxicity
Side effects include burning sensation, irritation, pruritus, erythema, and skin infections, at the application site.
Sal seidlitense Patient Information
Sal seidlitense Organisms Affected
Humans and other mammals
